Diabetes Care Devices – Market Insights – United States

The US diabetes care device market will see strong growth over the forecast period, spurred by various factors, namely FDA approvals for new products with expanded indications, strong growth in the CGM device segment, the growing diabetes population, and the continued innovation of devices in this sector.

This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2034.

The US diabetes care device market will grow strongly through 2034.

How will growth vary between product segments?

What are the factors driving market expansion?

Innovation will drive growth in the US diabetes care device market.

What are some recent technological innovations that have enhanced the capabilities of devices in this market? 

Diabetes care devices are getting approved for use by a wider range of people with type 2 diabetes.

Which product segments have received approvals for type 2 diabetes population?

How will expanded approvals impact the overall market?

GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.

How will adoption of GLP-1 receptor agonists affect the US diabetes care device market?

Which market segments will be more impacted by the growing popularity of GLP-1 receptor agonists?

Numerous new competitors and products are expected to enter this space within the forecast period.

Who are these competitors and what products are they bringing to the market?

How will the new entrants affect the existing competitive space?